nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Rivastigmine—Alzheimer's disease	0.2	0.432	CbGbCtD
Tadalafil—CYP3A4—Donepezil—Alzheimer's disease	0.16	0.345	CbGbCtD
Tadalafil—CYP3A4—Galantamine—Alzheimer's disease	0.103	0.223	CbGbCtD
Tadalafil—PDE5A—blood vessel—Alzheimer's disease	0.00544	0.262	CbGeAlD
Tadalafil—PDE11A—brain—Alzheimer's disease	0.00313	0.151	CbGeAlD
Tadalafil—PDE5A—forebrain—Alzheimer's disease	0.00287	0.138	CbGeAlD
Tadalafil—PDE5A—telencephalon—Alzheimer's disease	0.00264	0.127	CbGeAlD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS2—Alzheimer's disease	0.0025	0.0435	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—Alzheimer's disease	0.00223	0.0388	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—HTR6—Alzheimer's disease	0.00216	0.0376	CbGpPWpGaD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS3—Alzheimer's disease	0.00201	0.035	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS3—Alzheimer's disease	0.00179	0.0312	CbGpPWpGaD
Tadalafil—PDE5A—nervous system—Alzheimer's disease	0.00156	0.0751	CbGeAlD
Tadalafil—PDE5A—central nervous system—Alzheimer's disease	0.0015	0.0723	CbGeAlD
Tadalafil—PDE5A—cerebellum—Alzheimer's disease	0.00147	0.0707	CbGeAlD
Tadalafil—PDE11A—G alpha (s) signalling events—IAPP—Alzheimer's disease	0.0014	0.0244	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—CRH—Alzheimer's disease	0.00136	0.0237	CbGpPWpGaD
Tadalafil—PDE11A—G alpha (s) signalling events—NPS—Alzheimer's disease	0.00129	0.0224	CbGpPWpGaD
Tadalafil—Urinary tract infection—Donepezil—Alzheimer's disease	0.00125	0.00273	CcSEcCtD
Tadalafil—Conjunctivitis—Donepezil—Alzheimer's disease	0.00125	0.00273	CcSEcCtD
Tadalafil—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00125	0.00272	CcSEcCtD
Tadalafil—Muscle spasms—Galantamine—Alzheimer's disease	0.00125	0.00272	CcSEcCtD
Tadalafil—Sweating—Donepezil—Alzheimer's disease	0.00123	0.00269	CcSEcCtD
Tadalafil—Bronchitis—Rivastigmine—Alzheimer's disease	0.00123	0.00269	CcSEcCtD
Tadalafil—Haematuria—Donepezil—Alzheimer's disease	0.00123	0.00268	CcSEcCtD
Tadalafil—Vision blurred—Galantamine—Alzheimer's disease	0.00122	0.00267	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00122	0.00266	CcSEcCtD
Tadalafil—Epistaxis—Donepezil—Alzheimer's disease	0.00121	0.00265	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00119	0.0026	CcSEcCtD
Tadalafil—PDE5A—brain—Alzheimer's disease	0.00119	0.0574	CbGeAlD
Tadalafil—PDE11A—Hemostasis—DOCK3—Alzheimer's disease	0.00118	0.0205	CbGpPWpGaD
Tadalafil—Infestation—Memantine—Alzheimer's disease	0.00117	0.00255	CcSEcCtD
Tadalafil—Infestation NOS—Memantine—Alzheimer's disease	0.00117	0.00255	CcSEcCtD
Tadalafil—Vertigo—Galantamine—Alzheimer's disease	0.00117	0.00254	CcSEcCtD
Tadalafil—Syncope—Galantamine—Alzheimer's disease	0.00116	0.00254	CcSEcCtD
Tadalafil—Haemoglobin—Donepezil—Alzheimer's disease	0.00116	0.00253	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00116	0.00253	CcSEcCtD
Tadalafil—Rhinitis—Donepezil—Alzheimer's disease	0.00116	0.00253	CcSEcCtD
Tadalafil—Haemorrhage—Donepezil—Alzheimer's disease	0.00116	0.00252	CcSEcCtD
Tadalafil—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00115	0.00251	CcSEcCtD
Tadalafil—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00115	0.00251	CcSEcCtD
Tadalafil—Renal failure—Memantine—Alzheimer's disease	0.00115	0.0025	CcSEcCtD
Tadalafil—Palpitations—Galantamine—Alzheimer's disease	0.00115	0.0025	CcSEcCtD
Tadalafil—Pharyngitis—Donepezil—Alzheimer's disease	0.00115	0.0025	CcSEcCtD
Tadalafil—Myocardial infarction—Memantine—Alzheimer's disease	0.00115	0.0025	CcSEcCtD
Tadalafil—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00114	0.00249	CcSEcCtD
Tadalafil—Infestation—Rivastigmine—Alzheimer's disease	0.00114	0.00249	CcSEcCtD
Tadalafil—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00114	0.00249	CcSEcCtD
Tadalafil—Loss of consciousness—Galantamine—Alzheimer's disease	0.00114	0.00249	CcSEcCtD
Tadalafil—Oedema peripheral—Donepezil—Alzheimer's disease	0.00114	0.00248	CcSEcCtD
Tadalafil—Urinary tract infection—Memantine—Alzheimer's disease	0.00114	0.00248	CcSEcCtD
Tadalafil—Conjunctivitis—Memantine—Alzheimer's disease	0.00114	0.00248	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00113	0.00247	CcSEcCtD
Tadalafil—Urethral disorder—Donepezil—Alzheimer's disease	0.00113	0.00247	CcSEcCtD
Tadalafil—Cough—Galantamine—Alzheimer's disease	0.00113	0.00247	CcSEcCtD
Tadalafil—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00113	0.00246	CcSEcCtD
Tadalafil—Convulsion—Galantamine—Alzheimer's disease	0.00112	0.00245	CcSEcCtD
Tadalafil—Renal failure—Rivastigmine—Alzheimer's disease	0.00112	0.00245	CcSEcCtD
Tadalafil—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00112	0.00244	CcSEcCtD
Tadalafil—Hypertension—Galantamine—Alzheimer's disease	0.00112	0.00244	CcSEcCtD
Tadalafil—Haematuria—Memantine—Alzheimer's disease	0.00111	0.00243	CcSEcCtD
Tadalafil—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00111	0.00242	CcSEcCtD
Tadalafil—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00111	0.00242	CcSEcCtD
Tadalafil—Arthralgia—Galantamine—Alzheimer's disease	0.00111	0.00241	CcSEcCtD
Tadalafil—Chest pain—Galantamine—Alzheimer's disease	0.00111	0.00241	CcSEcCtD
Tadalafil—Myalgia—Galantamine—Alzheimer's disease	0.00111	0.00241	CcSEcCtD
Tadalafil—Epistaxis—Memantine—Alzheimer's disease	0.0011	0.0024	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.0011	0.00239	CcSEcCtD
Tadalafil—Sweating—Rivastigmine—Alzheimer's disease	0.0011	0.00239	CcSEcCtD
Tadalafil—Discomfort—Galantamine—Alzheimer's disease	0.00109	0.00238	CcSEcCtD
Tadalafil—Haematuria—Rivastigmine—Alzheimer's disease	0.00109	0.00238	CcSEcCtD
Tadalafil—Dry mouth—Galantamine—Alzheimer's disease	0.00108	0.00236	CcSEcCtD
Tadalafil—Epistaxis—Rivastigmine—Alzheimer's disease	0.00108	0.00235	CcSEcCtD
Tadalafil—Tinnitus—Donepezil—Alzheimer's disease	0.00108	0.00235	CcSEcCtD
Tadalafil—Haemoglobin—Memantine—Alzheimer's disease	0.00105	0.0023	CcSEcCtD
Tadalafil—Rhinitis—Memantine—Alzheimer's disease	0.00105	0.00229	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—DOCK3—Alzheimer's disease	0.00105	0.0183	CbGpPWpGaD
Tadalafil—Haemorrhage—Memantine—Alzheimer's disease	0.00105	0.00229	CcSEcCtD
Tadalafil—Hypoaesthesia—Memantine—Alzheimer's disease	0.00104	0.00228	CcSEcCtD
Tadalafil—Shock—Galantamine—Alzheimer's disease	0.00104	0.00227	CcSEcCtD
Tadalafil—Pharyngitis—Memantine—Alzheimer's disease	0.00104	0.00227	CcSEcCtD
Tadalafil—Nervous system disorder—Galantamine—Alzheimer's disease	0.00104	0.00227	CcSEcCtD
Tadalafil—Urinary tract disorder—Memantine—Alzheimer's disease	0.00104	0.00226	CcSEcCtD
Tadalafil—Tachycardia—Galantamine—Alzheimer's disease	0.00103	0.00225	CcSEcCtD
Tadalafil—Oedema peripheral—Memantine—Alzheimer's disease	0.00103	0.00225	CcSEcCtD
Tadalafil—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00103	0.00225	CcSEcCtD
Tadalafil—Connective tissue disorder—Memantine—Alzheimer's disease	0.00103	0.00225	CcSEcCtD
Tadalafil—Rhinitis—Rivastigmine—Alzheimer's disease	0.00103	0.00224	CcSEcCtD
Tadalafil—Skin disorder—Galantamine—Alzheimer's disease	0.00103	0.00224	CcSEcCtD
Tadalafil—Urethral disorder—Memantine—Alzheimer's disease	0.00103	0.00224	CcSEcCtD
Tadalafil—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00103	0.00224	CcSEcCtD
Tadalafil—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00102	0.00223	CcSEcCtD
Tadalafil—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00102	0.00223	CcSEcCtD
Tadalafil—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00102	0.00222	CcSEcCtD
Tadalafil—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00101	0.00221	CcSEcCtD
Tadalafil—Mental disorder—Donepezil—Alzheimer's disease	0.00101	0.00221	CcSEcCtD
Tadalafil—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00101	0.0022	CcSEcCtD
Tadalafil—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00101	0.0022	CcSEcCtD
Tadalafil—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00101	0.00219	CcSEcCtD
Tadalafil—Erythema multiforme—Memantine—Alzheimer's disease	0.000992	0.00216	CcSEcCtD
Tadalafil—Hypotension—Galantamine—Alzheimer's disease	0.00099	0.00216	CcSEcCtD
Tadalafil—Eye disorder—Memantine—Alzheimer's disease	0.000981	0.00214	CcSEcCtD
Tadalafil—Tinnitus—Memantine—Alzheimer's disease	0.000978	0.00213	CcSEcCtD
Tadalafil—Flushing—Memantine—Alzheimer's disease	0.000974	0.00212	CcSEcCtD
Tadalafil—Cardiac disorder—Memantine—Alzheimer's disease	0.000974	0.00212	CcSEcCtD
Tadalafil—Back pain—Donepezil—Alzheimer's disease	0.000973	0.00212	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS2—Alzheimer's disease	0.000973	0.0169	CbGpPWpGaD
Tadalafil—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000971	0.00212	CcSEcCtD
Tadalafil—Muscle spasms—Donepezil—Alzheimer's disease	0.000967	0.00211	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000965	0.0021	CcSEcCtD
Tadalafil—Eye disorder—Rivastigmine—Alzheimer's disease	0.000959	0.00209	CcSEcCtD
Tadalafil—Insomnia—Galantamine—Alzheimer's disease	0.000958	0.00209	CcSEcCtD
Tadalafil—Tinnitus—Rivastigmine—Alzheimer's disease	0.000957	0.00209	CcSEcCtD
Tadalafil—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000953	0.00208	CcSEcCtD
Tadalafil—Flushing—Rivastigmine—Alzheimer's disease	0.000953	0.00208	CcSEcCtD
Tadalafil—Angiopathy—Memantine—Alzheimer's disease	0.000952	0.00208	CcSEcCtD
Tadalafil—Paraesthesia—Galantamine—Alzheimer's disease	0.000951	0.00207	CcSEcCtD
Tadalafil—Vision blurred—Donepezil—Alzheimer's disease	0.000948	0.00207	CcSEcCtD
Tadalafil—Immune system disorder—Memantine—Alzheimer's disease	0.000948	0.00207	CcSEcCtD
Tadalafil—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.000947	0.0165	CbGpPWpGaD
Tadalafil—Mediastinal disorder—Memantine—Alzheimer's disease	0.000946	0.00206	CcSEcCtD
Tadalafil—Somnolence—Galantamine—Alzheimer's disease	0.000942	0.00205	CcSEcCtD
Tadalafil—Dyspepsia—Galantamine—Alzheimer's disease	0.000933	0.00203	CcSEcCtD
Tadalafil—Angiopathy—Rivastigmine—Alzheimer's disease	0.000931	0.00203	CcSEcCtD
Tadalafil—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000925	0.00202	CcSEcCtD
Tadalafil—Mental disorder—Memantine—Alzheimer's disease	0.000919	0.002	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000915	0.00199	CcSEcCtD
Tadalafil—Fatigue—Galantamine—Alzheimer's disease	0.000913	0.00199	CcSEcCtD
Tadalafil—Constipation—Galantamine—Alzheimer's disease	0.000906	0.00198	CcSEcCtD
Tadalafil—Vertigo—Donepezil—Alzheimer's disease	0.000904	0.00197	CcSEcCtD
Tadalafil—Syncope—Donepezil—Alzheimer's disease	0.000902	0.00197	CcSEcCtD
Tadalafil—Mental disorder—Rivastigmine—Alzheimer's disease	0.000899	0.00196	CcSEcCtD
Tadalafil—Loss of consciousness—Donepezil—Alzheimer's disease	0.000884	0.00193	CcSEcCtD
Tadalafil—Back pain—Memantine—Alzheimer's disease	0.000884	0.00193	CcSEcCtD
Tadalafil—Cough—Donepezil—Alzheimer's disease	0.000878	0.00191	CcSEcCtD
Tadalafil—Convulsion—Donepezil—Alzheimer's disease	0.000872	0.0019	CcSEcCtD
Tadalafil—Hypertension—Donepezil—Alzheimer's disease	0.000869	0.00189	CcSEcCtD
Tadalafil—PDE5A—Platelet homeostasis—NOS2—Alzheimer's disease	0.000867	0.0151	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000866	0.00189	CcSEcCtD
Tadalafil—Back pain—Rivastigmine—Alzheimer's disease	0.000864	0.00188	CcSEcCtD
Tadalafil—Vision blurred—Memantine—Alzheimer's disease	0.000861	0.00188	CcSEcCtD
Tadalafil—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000859	0.00187	CcSEcCtD
Tadalafil—Chest pain—Donepezil—Alzheimer's disease	0.000856	0.00187	CcSEcCtD
Tadalafil—Arthralgia—Donepezil—Alzheimer's disease	0.000856	0.00187	CcSEcCtD
Tadalafil—Myalgia—Donepezil—Alzheimer's disease	0.000856	0.00187	CcSEcCtD
Tadalafil—Discomfort—Donepezil—Alzheimer's disease	0.000846	0.00184	CcSEcCtD
Tadalafil—Vision blurred—Rivastigmine—Alzheimer's disease	0.000842	0.00184	CcSEcCtD
Tadalafil—Dry mouth—Donepezil—Alzheimer's disease	0.000838	0.00183	CcSEcCtD
Tadalafil—Abdominal pain—Galantamine—Alzheimer's disease	0.000837	0.00183	CcSEcCtD
Tadalafil—Oedema—Donepezil—Alzheimer's disease	0.000821	0.00179	CcSEcCtD
Tadalafil—Vertigo—Memantine—Alzheimer's disease	0.000821	0.00179	CcSEcCtD
Tadalafil—Syncope—Memantine—Alzheimer's disease	0.000819	0.00179	CcSEcCtD
Tadalafil—Infection—Donepezil—Alzheimer's disease	0.000816	0.00178	CcSEcCtD
Tadalafil—Shock—Donepezil—Alzheimer's disease	0.000808	0.00176	CcSEcCtD
Tadalafil—Palpitations—Memantine—Alzheimer's disease	0.000807	0.00176	CcSEcCtD
Tadalafil—Nervous system disorder—Donepezil—Alzheimer's disease	0.000805	0.00176	CcSEcCtD
Tadalafil—Vertigo—Rivastigmine—Alzheimer's disease	0.000803	0.00175	CcSEcCtD
Tadalafil—Loss of consciousness—Memantine—Alzheimer's disease	0.000803	0.00175	CcSEcCtD
Tadalafil—Syncope—Rivastigmine—Alzheimer's disease	0.000801	0.00175	CcSEcCtD
Tadalafil—Cough—Memantine—Alzheimer's disease	0.000797	0.00174	CcSEcCtD
Tadalafil—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000794	0.00173	CcSEcCtD
Tadalafil—Convulsion—Memantine—Alzheimer's disease	0.000791	0.00173	CcSEcCtD
Tadalafil—Palpitations—Rivastigmine—Alzheimer's disease	0.00079	0.00172	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.00079	0.0137	CbGpPWpGaD
Tadalafil—Hypertension—Memantine—Alzheimer's disease	0.000789	0.00172	CcSEcCtD
Tadalafil—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000785	0.00171	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS3—Alzheimer's disease	0.000782	0.0136	CbGpPWpGaD
Tadalafil—Hypersensitivity—Galantamine—Alzheimer's disease	0.000781	0.0017	CcSEcCtD
Tadalafil—Cough—Rivastigmine—Alzheimer's disease	0.00078	0.0017	CcSEcCtD
Tadalafil—Arthralgia—Memantine—Alzheimer's disease	0.000778	0.0017	CcSEcCtD
Tadalafil—Myalgia—Memantine—Alzheimer's disease	0.000778	0.0017	CcSEcCtD
Tadalafil—Chest pain—Memantine—Alzheimer's disease	0.000778	0.0017	CcSEcCtD
Tadalafil—Convulsion—Rivastigmine—Alzheimer's disease	0.000774	0.00169	CcSEcCtD
Tadalafil—Hypertension—Rivastigmine—Alzheimer's disease	0.000771	0.00168	CcSEcCtD
Tadalafil—Discomfort—Memantine—Alzheimer's disease	0.000768	0.00168	CcSEcCtD
Tadalafil—Hypotension—Donepezil—Alzheimer's disease	0.000767	0.00167	CcSEcCtD
Tadalafil—Myalgia—Rivastigmine—Alzheimer's disease	0.000761	0.00166	CcSEcCtD
Tadalafil—Chest pain—Rivastigmine—Alzheimer's disease	0.000761	0.00166	CcSEcCtD
Tadalafil—Arthralgia—Rivastigmine—Alzheimer's disease	0.000761	0.00166	CcSEcCtD
Tadalafil—Dry mouth—Memantine—Alzheimer's disease	0.000761	0.00166	CcSEcCtD
Tadalafil—Asthenia—Galantamine—Alzheimer's disease	0.00076	0.00166	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000755	0.00165	CcSEcCtD
Tadalafil—Discomfort—Rivastigmine—Alzheimer's disease	0.000752	0.00164	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000748	0.00163	CcSEcCtD
Tadalafil—Oedema—Memantine—Alzheimer's disease	0.000745	0.00163	CcSEcCtD
Tadalafil—Dry mouth—Rivastigmine—Alzheimer's disease	0.000744	0.00162	CcSEcCtD
Tadalafil—Insomnia—Donepezil—Alzheimer's disease	0.000743	0.00162	CcSEcCtD
Tadalafil—Infection—Memantine—Alzheimer's disease	0.000741	0.00161	CcSEcCtD
Tadalafil—Paraesthesia—Donepezil—Alzheimer's disease	0.000737	0.00161	CcSEcCtD
Tadalafil—Shock—Memantine—Alzheimer's disease	0.000733	0.0016	CcSEcCtD
Tadalafil—Dyspnoea—Donepezil—Alzheimer's disease	0.000732	0.0016	CcSEcCtD
Tadalafil—Nervous system disorder—Memantine—Alzheimer's disease	0.000731	0.00159	CcSEcCtD
Tadalafil—Somnolence—Donepezil—Alzheimer's disease	0.00073	0.00159	CcSEcCtD
Tadalafil—Oedema—Rivastigmine—Alzheimer's disease	0.000729	0.00159	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—CDK5—Alzheimer's disease	0.000728	0.0127	CbGpPWpGaD
Tadalafil—Tachycardia—Memantine—Alzheimer's disease	0.000728	0.00159	CcSEcCtD
Tadalafil—Diarrhoea—Galantamine—Alzheimer's disease	0.000725	0.00158	CcSEcCtD
Tadalafil—Infection—Rivastigmine—Alzheimer's disease	0.000724	0.00158	CcSEcCtD
Tadalafil—Skin disorder—Memantine—Alzheimer's disease	0.000724	0.00158	CcSEcCtD
Tadalafil—Dyspepsia—Donepezil—Alzheimer's disease	0.000723	0.00158	CcSEcCtD
Tadalafil—Hyperhidrosis—Memantine—Alzheimer's disease	0.000721	0.00157	CcSEcCtD
Tadalafil—Shock—Rivastigmine—Alzheimer's disease	0.000717	0.00156	CcSEcCtD
Tadalafil—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000715	0.00156	CcSEcCtD
Tadalafil—Tachycardia—Rivastigmine—Alzheimer's disease	0.000712	0.00155	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000709	0.00155	CcSEcCtD
Tadalafil—Skin disorder—Rivastigmine—Alzheimer's disease	0.000708	0.00154	CcSEcCtD
Tadalafil—Fatigue—Donepezil—Alzheimer's disease	0.000708	0.00154	CcSEcCtD
Tadalafil—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000705	0.00154	CcSEcCtD
Tadalafil—Pain—Donepezil—Alzheimer's disease	0.000702	0.00153	CcSEcCtD
Tadalafil—Constipation—Donepezil—Alzheimer's disease	0.000702	0.00153	CcSEcCtD
Tadalafil—Dizziness—Galantamine—Alzheimer's disease	0.000701	0.00153	CcSEcCtD
Tadalafil—PDE5A—Platelet homeostasis—NOS3—Alzheimer's disease	0.000697	0.0121	CbGpPWpGaD
Tadalafil—Hypotension—Memantine—Alzheimer's disease	0.000697	0.00152	CcSEcCtD
Tadalafil—Hypotension—Rivastigmine—Alzheimer's disease	0.000681	0.00149	CcSEcCtD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00068	0.0118	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000679	0.00148	CcSEcCtD
Tadalafil—Insomnia—Memantine—Alzheimer's disease	0.000674	0.00147	CcSEcCtD
Tadalafil—Vomiting—Galantamine—Alzheimer's disease	0.000674	0.00147	CcSEcCtD
Tadalafil—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000671	0.00146	CcSEcCtD
Tadalafil—Paraesthesia—Memantine—Alzheimer's disease	0.000669	0.00146	CcSEcCtD
Tadalafil—Rash—Galantamine—Alzheimer's disease	0.000668	0.00146	CcSEcCtD
Tadalafil—Dermatitis—Galantamine—Alzheimer's disease	0.000667	0.00145	CcSEcCtD
Tadalafil—Dyspnoea—Memantine—Alzheimer's disease	0.000665	0.00145	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000664	0.00145	CcSEcCtD
Tadalafil—Headache—Galantamine—Alzheimer's disease	0.000664	0.00145	CcSEcCtD
Tadalafil—Somnolence—Memantine—Alzheimer's disease	0.000663	0.00144	CcSEcCtD
Tadalafil—Insomnia—Rivastigmine—Alzheimer's disease	0.00066	0.00144	CcSEcCtD
Tadalafil—Dyspepsia—Memantine—Alzheimer's disease	0.000656	0.00143	CcSEcCtD
Tadalafil—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000655	0.00143	CcSEcCtD
Tadalafil—Urticaria—Donepezil—Alzheimer's disease	0.000652	0.00142	CcSEcCtD
Tadalafil—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00065	0.00142	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—CDK5—Alzheimer's disease	0.000649	0.0113	CbGpPWpGaD
Tadalafil—Abdominal pain—Donepezil—Alzheimer's disease	0.000649	0.00141	CcSEcCtD
Tadalafil—Somnolence—Rivastigmine—Alzheimer's disease	0.000648	0.00141	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000644	0.0014	CcSEcCtD
Tadalafil—Fatigue—Memantine—Alzheimer's disease	0.000643	0.0014	CcSEcCtD
Tadalafil—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000642	0.0014	CcSEcCtD
Tadalafil—Pain—Memantine—Alzheimer's disease	0.000637	0.00139	CcSEcCtD
Tadalafil—Constipation—Memantine—Alzheimer's disease	0.000637	0.00139	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00063	0.00137	CcSEcCtD
Tadalafil—Nausea—Galantamine—Alzheimer's disease	0.000629	0.00137	CcSEcCtD
Tadalafil—Fatigue—Rivastigmine—Alzheimer's disease	0.000629	0.00137	CcSEcCtD
Tadalafil—Pain—Rivastigmine—Alzheimer's disease	0.000624	0.00136	CcSEcCtD
Tadalafil—Constipation—Rivastigmine—Alzheimer's disease	0.000624	0.00136	CcSEcCtD
Tadalafil—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00061	0.00133	CcSEcCtD
Tadalafil—Hypersensitivity—Donepezil—Alzheimer's disease	0.000605	0.00132	CcSEcCtD
Tadalafil—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000596	0.0013	CcSEcCtD
Tadalafil—Urticaria—Memantine—Alzheimer's disease	0.000592	0.00129	CcSEcCtD
Tadalafil—Abdominal pain—Memantine—Alzheimer's disease	0.000589	0.00128	CcSEcCtD
Tadalafil—Asthenia—Donepezil—Alzheimer's disease	0.000589	0.00128	CcSEcCtD
Tadalafil—Pruritus—Donepezil—Alzheimer's disease	0.000581	0.00127	CcSEcCtD
Tadalafil—Urticaria—Rivastigmine—Alzheimer's disease	0.000579	0.00126	CcSEcCtD
Tadalafil—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000576	0.00126	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—CLU—Alzheimer's disease	0.000576	0.01	CbGpPWpGaD
Tadalafil—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000574	0.00999	CbGpPWpGaD
Tadalafil—Diarrhoea—Donepezil—Alzheimer's disease	0.000562	0.00122	CcSEcCtD
Tadalafil—Hypersensitivity—Memantine—Alzheimer's disease	0.000549	0.0012	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000547	0.00953	CbGpPWpGaD
Tadalafil—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000544	0.00947	CbGpPWpGaD
Tadalafil—Dizziness—Donepezil—Alzheimer's disease	0.000543	0.00118	CcSEcCtD
Tadalafil—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000537	0.00117	CcSEcCtD
Tadalafil—Asthenia—Memantine—Alzheimer's disease	0.000535	0.00117	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—PYY—Alzheimer's disease	0.000531	0.00924	CbGpPWpGaD
Tadalafil—Pruritus—Memantine—Alzheimer's disease	0.000527	0.00115	CcSEcCtD
Tadalafil—Asthenia—Rivastigmine—Alzheimer's disease	0.000523	0.00114	CcSEcCtD
Tadalafil—Vomiting—Donepezil—Alzheimer's disease	0.000522	0.00114	CcSEcCtD
Tadalafil—Rash—Donepezil—Alzheimer's disease	0.000518	0.00113	CcSEcCtD
Tadalafil—Dermatitis—Donepezil—Alzheimer's disease	0.000517	0.00113	CcSEcCtD
Tadalafil—Pruritus—Rivastigmine—Alzheimer's disease	0.000516	0.00112	CcSEcCtD
Tadalafil—Headache—Donepezil—Alzheimer's disease	0.000514	0.00112	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—A2M—Alzheimer's disease	0.000513	0.00893	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CLU—Alzheimer's disease	0.000513	0.00893	CbGpPWpGaD
Tadalafil—Diarrhoea—Memantine—Alzheimer's disease	0.00051	0.00111	CcSEcCtD
Tadalafil—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000499	0.00109	CcSEcCtD
Tadalafil—Dizziness—Memantine—Alzheimer's disease	0.000493	0.00107	CcSEcCtD
Tadalafil—Nausea—Donepezil—Alzheimer's disease	0.000488	0.00106	CcSEcCtD
Tadalafil—CYP3A4—nervous system—Alzheimer's disease	0.000486	0.0234	CbGeAlD
Tadalafil—Dizziness—Rivastigmine—Alzheimer's disease	0.000482	0.00105	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—PYY—Alzheimer's disease	0.000482	0.00839	CbGpPWpGaD
Tadalafil—Vomiting—Memantine—Alzheimer's disease	0.000474	0.00103	CcSEcCtD
Tadalafil—Rash—Memantine—Alzheimer's disease	0.00047	0.00102	CcSEcCtD
Tadalafil—Dermatitis—Memantine—Alzheimer's disease	0.00047	0.00102	CcSEcCtD
Tadalafil—CYP3A4—central nervous system—Alzheimer's disease	0.000468	0.0225	CbGeAlD
Tadalafil—Headache—Memantine—Alzheimer's disease	0.000467	0.00102	CcSEcCtD
Tadalafil—Vomiting—Rivastigmine—Alzheimer's disease	0.000464	0.00101	CcSEcCtD
Tadalafil—Rash—Rivastigmine—Alzheimer's disease	0.00046	0.001	CcSEcCtD
Tadalafil—Dermatitis—Rivastigmine—Alzheimer's disease	0.000459	0.001	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—A2M—Alzheimer's disease	0.000457	0.00796	CbGpPWpGaD
Tadalafil—Headache—Rivastigmine—Alzheimer's disease	0.000457	0.000996	CcSEcCtD
Tadalafil—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000455	0.00792	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000443	0.00771	CbGpPWpGaD
Tadalafil—Nausea—Memantine—Alzheimer's disease	0.000443	0.000965	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—INPP5D—Alzheimer's disease	0.000441	0.00768	CbGpPWpGaD
Tadalafil—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000437	0.00762	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TF—Alzheimer's disease	0.000436	0.0076	CbGpPWpGaD
Tadalafil—Nausea—Rivastigmine—Alzheimer's disease	0.000433	0.000944	CcSEcCtD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000426	0.00742	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00042	0.00732	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CDK5—Alzheimer's disease	0.000418	0.00728	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR6—Alzheimer's disease	0.000402	0.00701	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—GAB2—Alzheimer's disease	0.000399	0.00695	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—INPP5D—Alzheimer's disease	0.000393	0.00685	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—APP—Alzheimer's disease	0.000389	0.00677	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TF—Alzheimer's disease	0.000389	0.00677	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GAL—Alzheimer's disease	0.000368	0.00641	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—GAB2—Alzheimer's disease	0.000356	0.00619	CbGpPWpGaD
Tadalafil—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000354	0.00617	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—APP—Alzheimer's disease	0.000347	0.00604	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000345	0.00601	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GAL—Alzheimer's disease	0.000334	0.00582	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TTR—Alzheimer's disease	0.000326	0.00567	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SOD1—Alzheimer's disease	0.000317	0.00552	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000314	0.00547	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IGF2—Alzheimer's disease	0.000301	0.00524	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NPY—Alzheimer's disease	0.000289	0.00503	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000287	0.005	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PYY—Alzheimer's disease	0.000285	0.00496	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SOD1—Alzheimer's disease	0.000283	0.00492	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CRH—Alzheimer's disease	0.000279	0.00486	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PRKCG—Alzheimer's disease	0.000271	0.00473	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IGF2—Alzheimer's disease	0.000268	0.00467	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000264	0.0046	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NPY—Alzheimer's disease	0.000262	0.00457	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000261	0.00454	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000258	0.00449	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CRH—Alzheimer's disease	0.000253	0.00441	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000252	0.00439	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—SST—Alzheimer's disease	0.000252	0.00439	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDK5—Alzheimer's disease	0.000247	0.0043	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—APP—Alzheimer's disease	0.000246	0.00428	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PRKCG—Alzheimer's disease	0.000242	0.00421	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NPS—Alzheimer's disease	0.00024	0.00418	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000239	0.00416	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR6—Alzheimer's disease	0.000238	0.00414	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLAU—Alzheimer's disease	0.000237	0.00413	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CALM1—Alzheimer's disease	0.000235	0.00409	CbGpPWpGaD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000233	0.00406	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000232	0.00404	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CAV1—Alzheimer's disease	0.000232	0.00404	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000229	0.00399	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—SST—Alzheimer's disease	0.000229	0.00399	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—APP—Alzheimer's disease	0.000223	0.00389	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—F2—Alzheimer's disease	0.000221	0.00384	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS2—Alzheimer's disease	0.000218	0.0038	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PSENEN—Alzheimer's disease	0.000216	0.00376	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APH1A—Alzheimer's disease	0.000213	0.00371	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLAU—Alzheimer's disease	0.000212	0.00368	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000211	0.00367	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CALM1—Alzheimer's disease	0.000209	0.00364	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000207	0.00361	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CAV1—Alzheimer's disease	0.000207	0.0036	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000206	0.00359	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LRP1—Alzheimer's disease	0.000202	0.00352	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GAL—Alzheimer's disease	0.000197	0.00344	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GFAP—Alzheimer's disease	0.000197	0.00344	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—F2—Alzheimer's disease	0.000197	0.00342	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS2—Alzheimer's disease	0.000194	0.00338	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IGF1—Alzheimer's disease	0.000193	0.00337	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000189	0.00329	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000186	0.00325	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000183	0.00319	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000181	0.00315	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS3—Alzheimer's disease	0.000175	0.00305	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—A2M—Alzheimer's disease	0.000174	0.00303	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IGF1—Alzheimer's disease	0.000172	0.003	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000172	0.00299	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000168	0.00293	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000163	0.00283	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000159	0.00277	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS3—Alzheimer's disease	0.000156	0.00272	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000156	0.00272	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000156	0.00271	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPY—Alzheimer's disease	0.000155	0.0027	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IAPP—Alzheimer's disease	0.000154	0.00268	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000153	0.00267	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CRH—Alzheimer's disease	0.00015	0.0026	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000148	0.00257	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000148	0.00257	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000144	0.00251	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPS—Alzheimer's disease	0.000142	0.00247	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000141	0.00246	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—F2—Alzheimer's disease	0.000139	0.00243	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000139	0.00242	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SST—Alzheimer's disease	0.000135	0.00236	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GAB2—Alzheimer's disease	0.000135	0.00236	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000135	0.00236	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000135	0.00235	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000134	0.00233	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APP—Alzheimer's disease	0.000132	0.0023	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—F2—Alzheimer's disease	0.000127	0.0022	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VEGFA—Alzheimer's disease	0.000126	0.0022	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000124	0.00217	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NGFR—Alzheimer's disease	0.000116	0.00202	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TGFB1—Alzheimer's disease	0.000116	0.00202	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000115	0.00201	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000113	0.00197	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000113	0.00196	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—Alzheimer's disease	0.000113	0.00196	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000109	0.00191	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—S100B—Alzheimer's disease	0.000107	0.00187	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TGFB1—Alzheimer's disease	0.000103	0.0018	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF2—Alzheimer's disease	0.000102	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF1R—Alzheimer's disease	9.87e-05	0.00172	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TP53—Alzheimer's disease	9.54e-05	0.00166	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LPL—Alzheimer's disease	9.46e-05	0.00165	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MEF2C—Alzheimer's disease	9.38e-05	0.00163	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCG—Alzheimer's disease	9.2e-05	0.0016	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NGF—Alzheimer's disease	8.96e-05	0.00156	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR5—Alzheimer's disease	8.72e-05	0.00152	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HTR2A—Alzheimer's disease	8.53e-05	0.00149	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—Alzheimer's disease	8.5e-05	0.00148	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	8.29e-05	0.00144	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	8.13e-05	0.00142	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—Alzheimer's disease	8.06e-05	0.0014	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	8.02e-05	0.0014	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CALM1—Alzheimer's disease	7.96e-05	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LEP—Alzheimer's disease	7.93e-05	0.00138	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOE—Alzheimer's disease	7.93e-05	0.00138	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CAV1—Alzheimer's disease	7.86e-05	0.00137	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ESR1—Alzheimer's disease	7.57e-05	0.00132	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2—Alzheimer's disease	7.48e-05	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.32e-05	0.00127	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—Alzheimer's disease	7.18e-05	0.00125	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GSK3B—Alzheimer's disease	6.87e-05	0.0012	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CREB1—Alzheimer's disease	6.81e-05	0.00119	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—INS—Alzheimer's disease	6.78e-05	0.00118	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL2—Alzheimer's disease	6.67e-05	0.00116	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF1—Alzheimer's disease	6.55e-05	0.00114	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOS3—Alzheimer's disease	5.94e-05	0.00103	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.09e-05	0.000887	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP3—Alzheimer's disease	5.04e-05	0.000878	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—Alzheimer's disease	5.01e-05	0.000873	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	4.7e-05	0.000818	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK8—Alzheimer's disease	4.64e-05	0.000807	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—Alzheimer's disease	4.62e-05	0.000805	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—Alzheimer's disease	4.28e-05	0.000745	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CA4—Alzheimer's disease	4e-05	0.000696	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—Alzheimer's disease	3.93e-05	0.000684	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.76e-05	0.000654	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.56e-05	0.00062	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.4e-05	0.000592	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.26e-05	0.000567	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—Alzheimer's disease	3.23e-05	0.000563	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.14e-05	0.000546	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.03e-05	0.000527	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—Alzheimer's disease	2.96e-05	0.000516	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—Alzheimer's disease	2.73e-05	0.000476	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.95e-05	0.00034	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.95e-05	0.00034	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.87e-05	0.000326	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.8e-05	0.000314	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.74e-05	0.000303	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.51e-05	0.000264	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.5e-05	0.00026	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.42e-05	0.000247	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.42e-05	0.000247	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.39e-05	0.000242	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.32e-05	0.00023	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.24e-05	0.000217	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.21e-05	0.00021	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.04e-05	0.000181	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.03e-05	0.00018	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPL—Alzheimer's disease	9.46e-06	0.000165	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	8.52e-06	0.000148	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.96e-06	0.000139	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.93e-06	0.000138	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.86e-06	0.000137	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.91e-06	0.00012	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—INS—Alzheimer's disease	6.78e-06	0.000118	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.94e-06	0.000103	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.44e-06	9.46e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.73e-06	4.76e-05	CbGpPWpGaD
